Quick Links

 ‭(Hidden)‬ Carolyn Behrendt, Ph.D.

Professional Experience

2007 - present, Associate Professor, Biostatistics and Epidemiology, Division of Information Sciences, City of Hope & Beckman Research Institute, Duarte, CA

2005 - 2007, Consultant, Department of Biostatistics, Genentech, Inc., South San Francisco, CA

2001 - 2005, Associate Director, Global Epidemiology, Safety and Risk Management, Pfizer Inc, San Diego, CA
 
1996 - 2000, Manager, Health Economics/Outcomes Research, Zeneca Pharmaceuticals, Wilmington, DE
 
1995 - 1996, Senior Epidemiologist, Infectious Disease, SmithKline Beecham Pharmaceuticals, Collegeville, PA
 
1993 - 1994, Research Fellow, T Cell Receptor Genetics, National Jewish Center for Immunology and Respiratory Medicine/University of Colorado School of Medicine, Denver, CO

1990 - 1992, Research Fellow, HIV/AIDS, Dept of Epidemiology, Johns Hopkins University School of Public Health, Baltimore, MD

Education and Training

1993 - 1994, National Jewish Center for Immunology and Respiratory Medicine/University of Colorado School of Medicine, Denver, CO, Postdoctorate fellowship, Immunogenetics
 
1993, Johns Hopkins University School of Public Health, Baltimore, MD, Ph.D., Epidemiology
 
1987, Case Western Reserve University, Cleveland, OH, B.A., Music/Liberal Arts


This is an abbreviated document. Full CV available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 06/08.

Honors and Awards
 
1996, Present Peer Reviewer for Journals including:

JAMA, Chest, Clinical Infectious Diseases, American Journal of Public Health, Journal of Viral Hepatitis,  Neuroepidemiology, Ophthalmic Epidemiology, I
Infection Control & Hospital Epidemiology
 
1991 - 1992, NIDA-NRSA HIV/AIDS Epidemiology Training Grant Awardee, Johns Hopkins University School of Public Health

 Search

Go!
Advanced Search Options
News & Publications Search

 Contact Information

To reach me or my staff,
call 626-256-HOPE (4673).

 Learn More

NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.